Vasopressin in Septic Shock Management

Introduction to Vasopressin

Vasopressin acts through several receptor subtypes, including V1a receptors that mediate vasoconstriction, V1b receptors that regulate ACTH release, V2 receptors that control anti-diuretic effects, oxytocin receptors that cause vasodilation, and purinergic receptors with limited relevance in septic shock 1
The key advantage of vasopressin is its V1a-receptor activation producing catecholamine-independent vasoconstriction, making it useful when patients become refractory to traditional catecholamines in septic shock 1

Patients with prolonged septic shock develop a relative vasopressin deficiency due to depletion of stores and inadequate synthesis 1
Vasopressin works through mechanisms independent of catecholamines 1
Low-dose infusion of vasopressin (0.01-0.04 units/min) increases blood pressure and decreases norepinephrine requirements 1

The American College of Critical Care Medicine recommends starting with a low-dose vasopressin (0.01-0.04 units/min) 2
The maximum dose for standard therapy is 0.03-0.04 units/min 2
Doses exceeding 0.04 units/min should be reserved for salvage therapy only (when other vasopressors have failed) 2
Vasopressin should be given as a continuous infusion with careful monitoring 3

Norepinephrine is recommended as the first-choice vasopressor (Grade 1B) 2
Vasopressin (up to 0.03 units/min) can be added to norepinephrine to either raise mean arterial pressure (MAP) to target or decrease norepinephrine dosage 2
Vasopressin should not be used as the single initial vasopressor for septic shock 2

Higher doses of vasopressin (>0.04 units/min) have been associated with cardiac, digital, and splanchnic ischemia 2
Vasopressin requires continuous arterial blood pressure monitoring 3
The safety and efficacy of vasopressin have not been established in pediatric patients 3

Start with norepinephrine as the primary vasopressor, and add vasopressin when target MAP cannot be maintained with norepinephrine alone or to reduce high-dose norepinephrine requirements
Start vasopressin at 0.01 units/min and titrate up to 0.03 units/min maximum
Continuously assess MAP, tissue perfusion (lactate, urine output, mental status)
Taper vasopressin only after norepinephrine requirements have significantly decreased 3